76162-915-35 : NDC 2026 Code

76162-915-35 : Levocetirizine Dihydrochloride Usp, 5 Mg ( Allergy Relief )

Additionally :

You can get information about “76162-915-35” NDC code in 76162-915-35 in HTML format

HTML | 76162-915-35 in TXT (Plain Text) format

TXT | 76162-915-35 in PDF (Portable Document Format)

PDF | 76162-915-35 in XML format

XML formats.

NDC Code : 76162-915-35 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "76162-915-35",
    "PackageDescription": "1 BOTTLE in 1 CARTON (76162-915-35)  / 35 TABLET, COATED in 1 BOTTLE",
    "NDC11Code": "76162-0915-35",
    "ProductNDC": "76162-915",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Allergy Relief",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Levocetirizine Dihydrochloride Usp, 5 Mg",
    "DosageFormName": "TABLET, COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260924",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA213513",
    "LabelerName": "Topco Associates, LLC",
    "SubstanceName": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "StrengthNumber": "5",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-09-28",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260924",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}